Clinical Trials · NCT00014586

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

TerminatedPhase 3Gonadorelin (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Enrollment
110
Start date
Jan 2001
Locations
1 site, Germany
Primary endpoint
Study in Prostate Cancer
View Gonadorelin compound reference